Skip to main content

Ventas Value Stock - Dividend - Research Selection

Ventas

ISIN: US92276F1003 , WKN: 878380

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of more than 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. References to ?Ventas? or the ?Company? mean Ventas, Inc. and its consolidated subsidiaries unless otherwise expressly noted. More information about Ventas and Lillibridge can be found at www.ventasreit.com and www.lillibridge.com.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Equity REITs: Takeaways From REITWeek 2024

2024-07-02
Overall positive outlook for REIT industry with a decline in development activity. Check out the key takeaways from REITWeek 2024.

Vitura: Kennedy Project Financing Schedule

2024-06-28
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Ex-Dividend Reminder: Ventas, ServisFirst Bancshares and Pegasystems

2024-06-27
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Real estate stocks edge down, while major market averages gain marginally

2024-06-22
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Equity Group-Backed Ardent Health Files for IPO in Second Try

2024-06-21
(Bloomberg) -- Hospital operator Ardent Health Partners Inc., whose majority owner is Equity Group Investments, has filed again for an initial public offering. Most Read from BloombergAt Blackstone’s $339 Billion Property Arm, the Honeymoon Is OverCDK Hackers Want Millions in Ransom to End Car Dealership OutageCar Dealers Reel From Cyberattack on $1.2 Trillion MarketApple Won’t Roll Out AI Tech In EU Market Over Regulatory ConcernsTennessee-based Ardent filed Friday with the US Securities and Ex

Analysts Are Bullish on Top Real Estate Stocks: Ventas (VTR), Ellington Financial (EFC)

2024-06-17
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Ventas (VTR) Gets a Buy from Mizuho Securities

2024-06-17
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

A Critical Cooldown

2024-06-16
U.S. equity markets posted a mixed performance this week. Click here to read more about the real estate weekly outlook, economic data, and the week ahead.

Three Key Themes From REITweek

2024-06-15
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Ventas price target raised by $1 at Scotiabank, here's why

2024-06-12
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.